VUMC News and Communications

Arteaga named to Komen scientific advisory board

Carlos Arteaga, M.D., associate director for Clinical Research and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been named to the Scientific Advisory Board of the Susan G. Komen for the Cure Breast Cancer Research Foundation.

VICC’s Hassanein lands lung cancer research grant

Mohamed Hassanein, Ph.D., research instructor in Pulmonary Medicine, has received a Career Development Award from the LUNGevity Foundation to work on the development of noninvasive tests to help diagnose lung cancer.

VUSM’s class of 2016 gets a jump on medical studies

July 23 was the first day of class for the VUSM class of 2016, a little more than a week earlier than the start of last year’s classes.

Proteins may point way to new prostate cancer drug targets

Two proteins that act in opposing directions – one that promotes cancer and one that suppresses cancer — regulate the same set of genes in prostate cancer, Vanderbilt-Ingram Cancer Center researchers have found.

VU study reveals connective tissue’s reinforcing ‘rivet’

An ancient enzyme that can be traced back 500 million years forms the chemical “rivet” that reinforces connective tissue throughout the body, Vanderbilt University researchers reported this week.

Biomarkers may offer autism clues

A combination of biomarkers may reveal new clues about causes of and potential interventions for autism.

1 351 352 353 354 355 416